|
|
|
|
|||||
|
|
|
COLUMBUS, Ga., Nov. 4, 2025 /PRNewswire/ -- November 4, 2025 - Aflac Incorporated (NYSE: AFL) today reported its third quarter results.
Total revenues were $4.7 billion in the third quarter of 2025, compared with $2.9 billion in the third quarter of 2024, primarily due to net investment gains of $275 million this quarter compared to net investment losses of $1.4 billion in the third quarter of 2024. Net earnings were $1.6 billion, or $3.08 per diluted share, compared with net losses of $93 million, or losses of $0.17 per diluted share a year ago.
Net earnings in the third quarter of 2025 included net investment gains of $275 million, or $0.52 per diluted share, compared with net investment losses of $1.4 billion, or $2.51 per diluted share a year ago. These net investment gains were driven by net gains of $285 million on certain derivatives and foreign currency activities; net gains from sales and redemptions of $33 million; a $10 million gain from an increase in the fair value of equity securities; and no impairments; offset by $53 million of current expected credit losses (CECL).
Adjusted earnings* in the third quarter were $1.3 billion, compared with $1.2 billion in the third quarter of 2024, reflecting an increase of 9.6%. Adjusted earnings per diluted share* increased 15.3% to $2.49 in the quarter. Variable investment income was in line with the company's long-term return expectations. The slightly stronger yen/dollar exchange rate did not impact adjusted earnings per share.
The average yen/dollar exchange rate in the third quarter of 2025 was 147.68, or 0.2% stronger than the average rate of 147.95 in the third quarter of 2024. For the first nine months, the average exchange rate was 148.03, or 1.7% stronger than the rate of 150.60 a year ago.
Shareholders' equity was $28.7 billion, or $54.57 per share, at September 30, 2025, compared with $24.8 billion, or $44.60 per share, at September 30, 2024. Shareholders' equity at the end of the third quarter included a cumulative increase of $6.8 billion for the effect of the change in discount rate assumptions on insurance reserves, compared with a corresponding cumulative decrease of $67 million at September 30, 2024 and a net unrealized loss on investment securities and derivatives of $1.7 billion, compared with a net unrealized gain of $537 million at September 30, 2024. Shareholders' equity at the end of the third quarter also included an unrealized foreign currency translation loss of $4.5 billion, compared with an unrealized foreign currency translation loss of $4.1 billion at September 30, 2024. The annualized return on average shareholders' equity in the third quarter was 23.5%.
For the first nine months of 2025, total revenues were down 9.1% to $12.3 billion, compared with $13.5 billion in the first nine months of 2024. Net earnings were $2.3 billion, or $4.21 per diluted share, compared with $3.5 billion, or $6.23 per diluted share, for the first nine months of 2024. Adjusted earnings for the first nine months of 2025 were $3.2 billion, or $5.92 per diluted share, compared with $3.2 billion, or $5.64 per diluted share, in 2024. Excluding the positive impact of $0.03 per share from the stronger yen/dollar exchange rate, adjusted earnings per diluted share increased 4.4% to $5.89 for the first nine months of 2025.
Shareholders' equity excluding AOCI (or adjusted book value*) was $28.0 billion, or $53.33 per share at September 30, 2025, compared with $28.5 billion, or $51.21 per share, at September 30, 2024. Adjusted book value excluding foreign currency remeasurement* was $24.4 billion, or $46.35 per share at September 30, 2025, compared with $24.3 billion, or $43.61 per share, at September 30, 2024. The annualized adjusted return on equity excluding foreign currency remeasurement* in the third quarter was 22.1%.
AFLAC JAPAN
In yen terms, Aflac Japan's net earned premiums were ¥245.2 billion for the quarter, or 4.0% lower than a year ago, mainly due to internal cancer reinsurance transactions. Adjusted net investment income was relatively flat at ¥98.0 billion, decreasing 0.9%. Total adjusted revenues in yen declined 3.1% to ¥344.2 billion. Pretax adjusted earnings in yen for the quarter increased 13.1% on a reported basis to ¥179.5 billion, primarily due to lower benefits from higher reserve remeasurement gains as a result of unlocking assumptions. Pretax adjusted earnings also increased 13.1% on a currency-neutral basis. The pretax adjusted profit margin for the Japan segment was 52.2%, compared with 44.7% a year ago.
For the first nine months, net earned premiums in yen were ¥756.2 billion, or 4.6% lower than a year ago. Adjusted net investment income decreased 6.5% to ¥288.4 billion. Total adjusted revenues in yen were down 5.1% to ¥1.0 trillion. Pretax adjusted earnings were ¥403.9 billion, or 2.4% lower than a year ago. As a result, the pretax adjusted profit margin for the Japan segment was 38.5%, compared with 37.5% a year ago.
In dollar terms, net earned premiums decreased 2.7% to $1.7 billion in the third quarter. Adjusted net investment income increased 0.5% to $665 million. Total adjusted revenues declined by 1.8% to $2.3 billion. Pretax adjusted earnings increased 13.3% to $1.2 billion.
For the first nine months, net earned premiums in dollars were $5.1 billion, or 2.6% lower than a year ago. Adjusted net investment income decreased 4.2% to $2.0 billion. Total adjusted revenues were down 3.0% to $7.1 billion. Pretax adjusted earnings were $2.7 billion, or 0.7% lower than a year ago.
For the quarter, total new annualized premium sales (sales) increased 11.8% to ¥19.6 billion, or $133 million, primarily reflecting strong sales of Miraito, the new cancer insurance product. For the first nine months, sales increased 16.1% to ¥54.4 billion, or $369 million.
AFLAC U.S.
Aflac U.S. net earned premiums increased 2.5% to $1.5 billion in the third quarter compared to the prior year, reflecting improved sales. Adjusted net investment income increased 1.9% to $214 million, primarily due to higher variable net investment income. Total adjusted revenues were up 2.6% to $1.7 billion. Pretax adjusted earnings were $375 million, 7.1% higher than a year ago, reflecting higher premiums and lower benefits, resulting from higher reserve remeasurement gains offset by higher expenses. As a result, the pretax adjusted profit margin for the U.S. segment was 21.7%, compared with 20.8% a year ago.
For the first nine months, net earned premiums increased 2.6% to $4.5 billion. Adjusted net investment income decreased 1.7% to $623 million. Total adjusted revenues were up 2.2% to $5.2 billion. Pretax adjusted earnings were $1.1 billion, or 2.9% higher than a year ago. As a result, the pretax adjusted profit margin for the U.S. segment was 21.7%, compared with 21.5% a year ago.
Aflac U.S. sales increased 2.8% in the quarter to $390 million, primarily benefiting from sales of group life and disability products. For the first nine months of the year, total new sales increased 3.0% to $1.0 billion.
CORPORATE AND OTHER
For the quarter, total adjusted revenues increased 52.4% to $343 million compared to the prior year. Internal reinsurance activity in the fourth quarter of 2024 drove an increase in both net earned premiums and adjusted net investment income. A lower volume of tax credit investments also contributed to higher adjusted net investment income. Total benefits and adjusted expenses increased $64 million compared to the prior year primarily due to reinsurance activity, higher costs pertaining to business operations, and higher interest expense, partially offset by higher reserve remeasurement gains. Pretax adjusted earnings were $69 million, compared with $15 million a year ago.
For the first nine months, total adjusted revenues increased 39.0% to $1.0 billion. Pretax adjusted earnings were $132 million, compared with $36 million a year ago.
DIVIDEND AND CAPITAL RETURNED TO SHAREHOLDERS
The board of directors declared the fourth quarter dividend of $0.58 per share, payable on December 1, 2025 to shareholders of record at the close of business on November 19, 2025.
In the third quarter, Aflac Incorporated deployed $1.0 billion in capital to repurchase 9.3 million of its common shares. At the end of September 2025, the company had 121.6 million remaining shares authorized for repurchase.
OUTLOOK
Commenting on the company's results, Aflac Incorporated Chairman and Chief Executive Officer Daniel P. Amos stated: "Aflac delivered very solid earnings for the quarter and the first nine months. These results reflect our focused efforts to execute on our strategy of creating long-term value for shareholders.
"Looking at our operations in Japan, I am pleased with Aflac Japan's 11.8% year-over-year sales increase in the quarter and ongoing strong premium persistency. The strong sales were driven largely by continued sales of our cancer insurance product Miraito, which was launched in March. We also continue to drive awareness for third sector protection to new and younger customers through our innovative first sector product Tsumitasu, which was repriced for new policies effective in September. Overall, I believe we have the right strategy to meet our customers' financial protection needs throughout their different life stages.
"In the U.S., I am pleased with our 2.5% increase in net earned premiums, which is supported by our strong persistency of 79% and a 2.8% increase in sales in the quarter. We are encouraged by the momentum we are seeing within all areas of our group business, especially our group life and disability as well as network dental. We continue to focus on more profitable growth through our stronger underwriting discipline and improving the productivity of agents and brokers. We are seeing improvement in net earned premiums and continue our prudent approach to expense management and maintaining a strong pretax margin.
"We continue to generate strong capital and cash flows while maintaining our commitment to prudent liquidity and capital management. We are pleased with our investments, which continue to produce strong net investment income. Especially as we celebrate Aflac's 70th anniversary this month, we treasure our 2025 milestone of 43 consecutive years of dividend increases and remain committed to extending this record, supported by our financial strength. We repurchased a record $1.0 billion in shares for the quarter. We intend to continue our balanced approach of investing in growth and driving long-term operating efficiencies."
*See Non-U.S. GAAP Financial Measures section for an explanation of foreign exchange and its impact on the financial statements and definitions of the non-U.S. GAAP financial measures used in this earnings release, as well as a reconciliation of such non-U.S. GAAP financial measures to the most comparable U.S. GAAP financial measures.
ABOUT AFLAC INCORPORATED
Aflac Incorporated (NYSE: AFL), a Fortune 500 company, has helped provide financial protection and peace of mind for seven decades to millions of policyholders and customers through its subsidiaries in the U.S. and Japan. In the U.S., Aflac is the No. 1 provider of supplemental health insurance products.1 In Japan, Aflac Life Insurance Japan is the leading provider of cancer and medical insurance in terms of policies in force. The company takes pride in being there for its policyholders when they need us most, as well as being included in the World's Most Ethical Companies by Ethisphere for 19 consecutive years (2025) and Fortune's World's Most Admired Companies for 24 years (2025). In addition, the company became a signatory of the Principles for Responsible Investment (PRI) in 2021 and has been included in the Dow Jones Sustainability North America Index (2024) for 11 years. To find out how to get help with expenses health insurance doesn't cover, get to know us at aflac.com or aflac.com/español. Investors may learn more about Aflac Incorporated and its commitment to corporate social responsibility and sustainability at investors.aflac.com under "Sustainability."
|
1LIMRA 2024 U.S. Supplemental Health Insurance Total Market Report |
|
|
|
A copy of Aflac's financial supplement for the quarter can be found on the "Investors" page at aflac.com. |
|
|
|
Aflac Incorporated will webcast its quarterly conference call via the "Investors" page of aflac.com at 8:00 a.m. (ET) on November 5, 2025. |
|
|
|
Note: Tables within this document may not foot due to rounding. |
|
AFLAC INCORPORATED AND SUBSIDIARIES CONDENSED INCOME STATEMENT |
||||||
|
(UNAUDITED – IN MILLIONS, EXCEPT FOR SHARE AND PER-SHARE AMOUNTS) |
||||||
|
|
|
|
|
|
|
|
|
THREE MONTHS ENDED SEPTEMBER 30, |
|
2025 |
|
2024 |
|
% Change |
|
Total revenues |
|
$ 4,740 |
|
$ 2,949 |
|
60.7 % |
|
Benefits and claims, net |
|
1,436 |
|
1,595 |
|
(10.0) |
|
Total acquisition and operating expenses |
|
1,310 |
|
1,262 |
|
3.8 |
|
Earnings before income taxes |
|
1,994 |
|
92 |
|
2,067.4 |
|
Income taxes |
|
355 |
|
185 |
|
|
|
Net earnings |
|
$ 1,639 |
|
$ (93) |
|
1,862.4 % |
|
Net earnings per share – basic |
|
$ 3.09 |
|
$ (0.17) |
|
1,917.6 % |
|
Net earnings per share – diluted |
|
3.08 |
|
(0.17) |
|
1,911.8 |
|
Shares used to compute earnings per share (000): |
|
|
|
|
|
|
|
Basic |
|
530,050 |
|
557,899 |
|
(5.0) % |
|
Diluted |
|
532,015 |
|
560,414 |
|
(5.1) |
|
Dividends paid per share |
|
$ 0.58 |
|
$ 0.50 |
|
16.0 % |
|
AFLAC INCORPORATED AND SUBSIDIARIES CONDENSED INCOME STATEMENT |
||||||
|
(UNAUDITED – IN MILLIONS, EXCEPT FOR SHARE AND PER-SHARE AMOUNTS) |
||||||
|
|
|
|
|
|
|
|
|
NINE MONTHS ENDED SEPTEMBER 30, |
|
2025 |
|
2024 |
|
% Change |
|
Total revenues |
|
$ 12,298 |
|
$ 13,524 |
|
(9.1) % |
|
Benefits and claims, net |
|
5,391 |
|
5,527 |
|
(2.5) |
|
Total acquisition and operating expenses |
|
3,946 |
|
3,715 |
|
6.2 |
|
Earnings before income taxes |
|
2,961 |
|
4,282 |
|
(30.9) |
|
Income taxes |
|
694 |
|
741 |
|
|
|
Net earnings |
|
$ 2,267 |
|
$ 3,541 |
|
(36.0) % |
|
Net earnings per share – basic |
|
$ 4.22 |
|
$ 6.26 |
|
(32.6) % |
|
Net earnings per share – diluted |
|
4.21 |
|
6.23 |
|
(32.4) |
|
Shares used to compute earnings per share (000): |
|
|
|
|
|
|
|
Basic |
|
537,095 |
|
565,757 |
|
(5.1) % |
|
Diluted |
|
539,052 |
|
568,216 |
|
(5.1) |
|
Dividends paid per share |
|
$ 1.74 |
|
$ 1.50 |
|
16.0 % |
|
AFLAC INCORPORATED AND SUBSIDIARIES CONDENSED BALANCE SHEET |
||||||
|
(UNAUDITED – IN MILLIONS, EXCEPT FOR SHARE AMOUNTS) |
||||||
|
|
|
|
|
|
|
|
|
SEPTEMBER 30, |
|
2025 |
|
2024 |
|
% Change |
|
Assets: |
|
|
|
|
|
|
|
Total investments and cash |
|
$ 109,516 |
|
$ 115,601 |
|
(5.3) % |
|
Deferred policy acquisition costs |
|
9,216 |
|
9,232 |
|
(0.2) |
|
Other assets |
|
3,574 |
|
3,609 |
|
(1.0) |
|
Total assets |
|
$ 122,306 |
|
$ 128,442 |
|
(4.8) % |
|
Liabilities and shareholders' equity: |
|
|
|
|
|
|
|
Policy liabilities |
|
$ 74,737 |
|
$ 87,554 |
|
(14.6) % |
|
Notes payable and lease obligations |
|
8,685 |
|
7,978 |
|
8.9 |
|
Other liabilities |
|
10,196 |
|
8,080 |
|
26.2 |
|
Shareholders' equity |
|
28,688 |
|
24,830 |
|
15.5 |
|
Total liabilities and shareholders' equity |
|
$ 122,306 |
|
$ 128,442 |
|
(4.8) % |
|
Shares outstanding at end of period (000) |
|
525,710 |
|
556,717 |
|
(5.6) % |
NON-U.S. GAAP FINANCIAL MEASURES
This document includes references to the Company's financial performance measures which are not calculated in accordance with United States generally accepted accounting principles (U.S. GAAP) (non-U.S. GAAP). The financial measures exclude items that the Company believes may obscure the underlying fundamentals and trends in insurance operations because they tend to be driven by general economic conditions and events or related to infrequent activities not directly associated with insurance operations.
Due to the size of Aflac Japan, where the functional currency is the Japanese yen, fluctuations in the yen/dollar exchange rate can have a significant effect on reported results. In periods when the yen weakens, translating yen into dollars results in fewer dollars being reported. When the yen strengthens, translating yen into dollars results in more dollars being reported. Consequently, yen weakening has the effect of suppressing current period results in relation to the comparable prior period, while yen strengthening has the effect of magnifying current period results in relation to the comparable prior period. A significant portion of the Company's business is conducted in yen and never converted into dollars but translated into dollars for U.S. GAAP reporting purposes, which results in foreign currency impact to earnings, cash flows and book value on a U.S. GAAP basis. Management evaluates the Company's financial performance both including and excluding the impact of foreign currency translation to monitor, respectively, cumulative currency impacts and the currency-neutral operating performance over time. The average yen/dollar exchange rate is based on the published MUFG Bank, Ltd. telegraphic transfer middle rate (TTM).
The company defines the non-U.S. GAAP financial measures included in this earnings release as follows:
|
RECONCILIATION OF NET EARNINGS TO ADJUSTED EARNINGS |
||||||
|
(UNAUDITED – IN MILLIONS, EXCEPT FOR PER-SHARE AMOUNTS) |
||||||
|
|
|
|
|
|
|
|
|
THREE MONTHS ENDED SEPTEMBER 30, |
|
2025 |
|
2024 |
|
% Change |
|
|
|
|
|
|
|
|
|
Net earnings |
|
$ 1,639 |
|
$ (93) |
|
1,862.4 % |
|
|
|
|
|
|
|
|
|
Items impacting net earnings: |
|
|
|
|
|
|
|
Adjusted net investment (gains) losses |
|
(335) |
|
1,347 |
|
|
|
Other and non-recurring (income) loss |
|
1 |
|
— |
|
|
|
Income tax (benefit) expense on items excluded from adjusted earnings |
|
22 |
|
(43) |
|
|
|
|
|
|
|
|
|
|
|
Adjusted earnings |
|
1,327 |
|
1,211 |
|
9.6 % |
|
Current period foreign currency impact1 |
|
(1) |
|
N/A |
|
|
|
Adjusted earnings excluding current period foreign |
|
$ 1,326 |
|
$ 1,211 |
|
9.5 % |
|
|
|
|
|
|
|
|
|
Net earnings per diluted share |
|
$ 3.08 |
|
$ (0.17) |
|
1,911.8 % |
|
|
|
|
|
|
|
|
|
Items impacting net earnings: |
|
|
|
|
|
|
|
Adjusted net investment (gains) losses |
|
(0.63) |
|
2.40 |
|
|
|
Other and non-recurring (income) loss |
|
— |
|
— |
|
|
|
Income tax (benefit) expense on items excluded from adjusted earnings |
|
0.04 |
|
(0.08) |
|
|
|
|
|
|
|
|
|
|
|
Adjusted earnings per diluted share |
|
2.49 |
|
2.16 |
|
15.3 % |
|
Current period foreign currency impact1 |
|
— |
|
N/A |
|
|
|
Adjusted earnings per diluted share excluding |
|
$ 2.49 |
|
$ 2.16 |
|
15.3 % |
|
|
|
|
1 |
Prior period foreign currency impact reflected as "N/A" to isolate change for current period only. |
|
2 |
Amounts excluding current period foreign currency impact are computed using the average foreign currency exchange rate for the comparable prior-year period, which eliminates fluctuations driven solely by foreign currency exchange rate changes. |
|
RECONCILIATION OF NET EARNINGS TO ADJUSTED EARNINGS |
||||||
|
(UNAUDITED – IN MILLIONS, EXCEPT FOR PER-SHARE AMOUNTS) |
||||||
|
|
|
|
|
|
|
|
|
NINE MONTHS ENDED SEPTEMBER 30, |
|
2025 |
|
2024 |
|
% Change |
|
|
|
|
|
|
|
|
|
Net earnings |
|
$ 2,267 |
|
$ 3,541 |
|
(36.0) % |
|
|
|
|
|
|
|
|
|
Items impacting net earnings: |
|
|
|
|
|
|
|
Adjusted net investment (gains) losses |
|
966 |
|
(411) |
|
|
|
Other and non-recurring (income) loss |
|
54 |
|
1 |
|
|
|
Income tax (benefit) expense on items excluded from adjusted earnings |
|
(97) |
|
76 |
|
|
|
|
|
|
|
|
|
|
|
Adjusted earnings |
|
3,190 |
|
3,207 |
|
(0.5) % |
|
Current period foreign currency impact1 |
|
(16) |
|
N/A |
|
|
|
Adjusted earnings excluding current period foreign |
|
$ 3,174 |
|
$ 3,207 |
|
(1.0) % |
|
|
|
|
|
|
|
|
|
Net earnings per diluted share |
|
$ 4.21 |
|
$ 6.23 |
|
(32.4) % |
|
|
|
|
|
|
|
|
|
Items impacting net earnings: |
|
|
|
|
|
|
|
Adjusted net investment (gains) losses |
|
1.79 |
|
(0.72) |
|
|
|
Other and non-recurring (income) loss |
|
0.10 |
|
— |
|
|
|
Income tax (benefit) expense on items excluded from adjusted earnings |
|
(0.18) |
|
0.13 |
|
|
|
|
|
|
|
|
|
|
|
Adjusted earnings per diluted share |
|
5.92 |
|
5.64 |
|
5.0 % |
|
Current period foreign currency impact1 |
|
(0.03) |
|
N/A |
|
|
|
Adjusted earnings per diluted share excluding |
|
$ 5.89 |
|
$ 5.64 |
|
4.4 % |
|
|
|
|
1 |
Prior period foreign currency impact reflected as "N/A" to isolate change for current period only. |
|
2 |
Amounts excluding current period foreign currency impact are computed using the average foreign currency exchange rate for the comparable prior-year period, which eliminates fluctuations driven solely by foreign currency exchange rate changes. |
|
RECONCILIATION OF NET INVESTMENT (GAINS) LOSSES TO ADJUSTED NET INVESTMENT (GAINS) LOSSES |
||||||
|
(UNAUDITED – IN MILLIONS) |
||||||
|
|
|
|
|
|
|
|
|
THREE MONTHS ENDED SEPTEMBER 30, |
|
2025 |
|
2024 |
|
% Change |
|
|
|
|
|
|
|
|
|
Net investment (gains) losses |
|
$ (275) |
|
$ 1,408 |
|
(119.5) % |
|
|
|
|
|
|
|
|
|
Items impacting net investment (gains) losses: |
|
|
|
|
|
|
|
Amortized hedge costs |
|
(13) |
|
(7) |
|
|
|
Amortized hedge income |
|
20 |
|
25 |
|
|
|
Net interest income (expense) from derivatives associated with certain investment strategies |
|
(66) |
|
(88) |
|
|
|
Impact of interest from derivatives associated with notes payable1 |
|
(1) |
|
8 |
|
|
|
|
|
|
|
|
|
|
|
Adjusted net investment (gains) losses |
|
$ (335) |
|
$ 1,347 |
|
(124.9) % |
|
|
|
1 Amounts are included with interest expenses that are a component of adjusted expenses. |
|
RECONCILIATION OF NET INVESTMENT INCOME TO ADJUSTED NET INVESTMENT INCOME |
||||||
|
(UNAUDITED – IN MILLIONS) |
||||||
|
|
|
|
|
|
|
|
|
THREE MONTHS ENDED SEPTEMBER 30, |
|
2025 |
|
2024 |
|
% Change |
|
|
|
|
|
|
|
|
|
Net investment income |
|
$ 1,067 |
|
$ 1,006 |
|
6.1 % |
|
|
|
|
|
|
|
|
|
Items impacting net investment income: |
|
|
|
|
|
|
|
Amortized hedge costs |
|
(13) |
|
(7) |
|
|
|
Amortized hedge income |
|
20 |
|
25 |
|
|
|
Net interest income (expense) from derivatives associated with certain investment strategies |
|
(66) |
|
(88) |
|
|
|
|
|
|
|
|
|
|
|
Adjusted net investment income |
|
$ 1,008 |
|
$ 936 |
|
7.7 % |
|
RECONCILIATION OF NET INVESTMENT (GAINS) LOSSES TO ADJUSTED NET INVESTMENT (GAINS) LOSSES |
||||||
|
(UNAUDITED – IN MILLIONS) |
||||||
|
|
|
|
|
|
|
|
|
NINE MONTHS ENDED SEPTEMBER 30, |
|
2025 |
|
2024 |
|
% Change |
|
|
|
|
|
|
|
|
|
Net investment (gains) losses |
|
$ 1,109 |
|
$ (239) |
|
564.0 % |
|
|
|
|
|
|
|
|
|
Items impacting net investment (gains) losses: |
|
|
|
|
|
|
|
Amortized hedge costs |
|
(31) |
|
(19) |
|
|
|
Amortized hedge income |
|
80 |
|
87 |
|
|
|
Net interest income (expense) from derivatives associated with certain investment strategies |
|
(195) |
|
(265) |
|
|
|
Impact of interest from derivatives associated with notes payable1 |
|
3 |
|
25 |
|
|
|
|
|
|
|
|
|
|
|
Adjusted net investment (gains) losses |
|
$ 966 |
|
$ (411) |
|
335.0 % |
|
1 Amounts are included with interest expenses that are a component of adjusted expenses. |
|
RECONCILIATION OF NET INVESTMENT INCOME TO ADJUSTED NET INVESTMENT INCOME |
||||||
|
(UNAUDITED – IN MILLIONS) |
||||||
|
|
|
|
|
|
|
|
|
NINE MONTHS ENDED SEPTEMBER 30, |
|
2025 |
|
2024 |
|
% Change |
|
|
|
|
|
|
|
|
|
Net investment income |
|
$ 3,103 |
|
$ 3,100 |
|
0.1 % |
|
|
|
|
|
|
|
|
|
Items impacting net investment income: |
|
|
|
|
|
|
|
Amortized hedge costs |
|
(31) |
|
(19) |
|
|
|
Amortized hedge income |
|
80 |
|
87 |
|
|
|
Net interest income (expense) from derivatives associated with certain investment strategies |
|
(195) |
|
(265) |
|
|
|
|
|
|
|
|
|
|
|
Adjusted net investment income |
|
$ 2,957 |
|
$ 2,903 |
|
1.9 % |
|
RECONCILIATION OF U.S. GAAP BOOK VALUE TO ADJUSTED BOOK VALUE |
||||||
|
(EXCLUDING FOREIGN CURRENCY REMEASUREMENT) |
||||||
|
(UNAUDITED - IN MILLIONS, EXCEPT FOR SHARE AND PER-SHARE AMOUNTS) |
||||||
|
|
|
|
|
|
|
|
|
SEPTEMBER 30, |
|
2025 |
|
2024 |
|
% Change |
|
U.S. GAAP book value |
|
$ 28,688 |
|
$ 24,830 |
|
|
|
Less: |
|
|
|
|
|
|
|
Unrealized foreign currency translation gains (losses) |
|
(4,504) |
|
(4,139) |
|
|
|
Unrealized gains (losses) on securities and derivatives |
|
(1,717) |
|
537 |
|
|
|
Effect of changes in discount rate assumptions |
|
6,832 |
|
(67) |
|
|
|
Pension liability adjustment |
|
42 |
|
(8) |
|
|
|
Total AOCI |
|
653 |
|
(3,677) |
|
|
|
Adjusted book value |
|
$ 28,035 |
|
$ 28,507 |
|
|
|
Less: |
|
|
|
|
|
|
|
Foreign currency remeasurement gains (losses) |
|
3,666 |
|
4,228 |
|
|
|
Adjusted book value excluding foreign currency remeasurement |
|
$ 24,369 |
|
$ 24,279 |
|
|
|
|
|
|
|
|
|
|
|
Number of outstanding shares at end of period (000) |
|
525,710 |
|
556,717 |
|
|
|
|
|
|
|
|
|
|
|
U.S. GAAP book value per common share |
|
$ 54.57 |
|
$ 44.60 |
|
22.4 % |
|
Less: |
|
|
|
|
|
|
|
Unrealized foreign currency translation gains (losses) per common share |
|
(8.57) |
|
(7.43) |
|
|
|
Unrealized gains (losses) on securities and derivatives per common share |
|
(3.27) |
|
0.96 |
|
|
|
Effect of changes in discount rate assumptions per common share |
|
13.00 |
|
(0.12) |
|
|
|
Pension liability adjustment per common share |
|
0.08 |
|
(0.01) |
|
|
|
Total AOCI per common share |
|
1.24 |
|
(6.60) |
|
|
|
Adjusted book value per common share |
|
$ 53.33 |
|
$ 51.21 |
|
4.1 % |
|
Less: |
|
|
|
|
|
|
|
Foreign currency remeasurement gains (losses) per common share |
|
6.97 |
|
7.59 |
|
|
|
Adjusted book value excluding foreign currency remeasurement per common share |
|
$ 46.35 |
|
$ 43.61 |
|
6.3 % |
|
RECONCILIATION OF U.S. GAAP RETURN ON EQUITY (ROE) TO ADJUSTED ROE |
||||
|
(EXCLUDING IMPACT OF FOREIGN CURRENCY) |
||||
|
|
|
|
|
|
|
THREE MONTHS ENDED SEPTEMBER 30, |
|
2025 |
|
2024 |
|
U.S. GAAP ROE - Net earnings1 |
|
23.5 % |
|
(1.5) % |
|
Impact of excluding unrealized foreign currency translation gains (losses) |
|
(5.4) |
|
0.3 |
|
Impact of excluding unrealized gains (losses) on securities and derivatives |
|
(2.2) |
|
— |
|
Impact of excluding effect of changes in discount rate assumptions |
|
7.7 |
|
— |
|
Impact of excluding pension liability adjustment |
|
0.1 |
|
— |
|
Impact of excluding AOCI |
|
0.1 |
|
0.2 |
|
U.S. GAAP ROE - less AOCI |
|
23.5 |
|
(1.3) |
|
Differences between adjusted earnings and net earnings2 |
|
(4.5) |
|
18.0 |
|
Adjusted ROE - reported |
|
19.1 |
|
16.7 |
|
Impact of excluding gains (losses) associated with foreign currency remeasurement3 |
|
3.0 |
|
3.5 |
|
Adjusted ROE, excluding foreign currency remeasurement |
|
22.1 |
|
20.2 |
|
|
|
|
1 |
U.S. GAAP ROE is calculated by dividing net earnings (annualized) by average shareholders' equity. |
|
2 |
See separate reconciliation of net income to adjusted earnings. |
|
3 |
Impact of gains/losses associated with foreign currency remeasurement is calculated by excluding the cumulative (beginning January 1, 2021) foreign currency gains/losses associated with i) foreign currency remeasurement and ii) sales and redemptions of invested assets. The impact is the difference of adjusted return on equity - reported compared with adjusted return on equity, excluding from shareholders' equity, gains/losses associated with foreign currency remeasurement. |
|
RECONCILIATION OF U.S. GAAP RETURN ON EQUITY (ROE) TO ADJUSTED ROE |
||||
|
(EXCLUDING IMPACT OF FOREIGN CURRENCY) |
||||
|
|
|
|
|
|
|
NINE MONTHS ENDED SEPTEMBER 30, |
|
2025 |
|
2024 |
|
U.S. GAAP ROE - Net earnings1 |
|
11.0 % |
|
20.2 % |
|
Impact of excluding unrealized foreign currency translation gains (losses) |
|
(1.6) |
|
(2.9) |
|
Impact of excluding unrealized gains (losses) on securities and derivatives |
|
(0.3) |
|
0.6 |
|
Impact of excluding effect of changes in discount rate assumptions |
|
1.5 |
|
(0.9) |
|
Impact of excluding pension liability adjustment |
|
— |
|
— |
|
Impact of excluding AOCI |
|
(0.4) |
|
(3.3) |
|
U.S. GAAP ROE - less AOCI |
|
10.6 |
|
16.9 |
|
Differences between adjusted earnings and net earnings2 |
|
4.3 |
|
(1.6) |
|
Adjusted ROE - reported |
|
14.9 |
|
15.3 |
|
Impact of excluding gains (losses) associated with foreign currency remeasurement3 |
|
2.9 |
|
2.5 |
|
Adjusted ROE, excluding foreign currency remeasurement |
|
17.8 |
|
17.8 |
|
1 |
U.S. GAAP ROE is calculated by dividing net earnings (annualized) by average shareholders' equity. |
|
2 |
See separate reconciliation of net income to adjusted earnings. |
|
3 |
Impact of gains/losses associated with foreign currency remeasurement is calculated by excluding the cumulative (beginning January 1, 2021) foreign currency gains/losses associated with i) foreign currency remeasurement and ii) sales and redemptions of invested assets. The impact is the difference of adjusted return on equity - reported compared with adjusted return on equity, excluding from shareholders' equity, gains/losses associated with foreign currency remeasurement. |
|
EFFECT OF FOREIGN CURRENCY ON ADJUSTED RESULTS 1 |
||||
|
(SELECTED PERCENTAGE CHANGES, UNAUDITED) |
||||
|
|
||||
|
THREE MONTHS ENDED SEPTEMBER 30, 2025 |
|
Including Currency Changes |
|
Excluding Currency Changes2 |
|
Net earned premiums3 |
|
1.3 % |
|
1.4 % |
|
Adjusted net investment income4 |
|
7.7 |
|
7.7 |
|
Total benefits and expenses |
|
(3.6) |
|
(3.5) |
|
Adjusted earnings |
|
9.6 |
|
9.5 |
|
Adjusted earnings per diluted share |
|
15.3 |
|
15.3 |
|
|
|
|
1 |
Refer to previously defined adjusted earnings and adjusted earnings per diluted share. |
|
2 |
Amounts excluding currency changes were determined using the same foreign currency exchange rate for the current period as the comparable period in the prior year, which eliminates dollar-based fluctuations driven solely from currency rate changes. |
|
3 |
Net of reinsurance |
|
4 |
Refer to previously defined adjusted net investment income. |
|
EFFECT OF FOREIGN CURRENCY ON ADJUSTED RESULTS 1 |
||||
|
(SELECTED PERCENTAGE CHANGES, UNAUDITED) |
||||
|
|
||||
|
NINE MONTHS ENDED SEPTEMBER 30, 2025 |
|
Including Currency Changes |
|
Excluding Currency Changes2 |
|
Net earned premiums3 |
|
1.1 % |
|
0.2 % |
|
Adjusted net investment income4 |
|
1.9 |
|
1.4 |
|
Total benefits and expenses |
|
0.7 |
|
(0.2) |
|
Adjusted earnings |
|
(0.5) |
|
(1.0) |
|
Adjusted earnings per diluted share |
|
5.0 |
|
4.4 |
|
|
|
|
1 |
Refer to previously defined adjusted earnings and adjusted earnings per diluted share. |
|
2 |
Amounts excluding currency changes were determined using the same foreign currency exchange rate for the current period as the comparable period in the prior year, which eliminates dollar-based fluctuations driven solely from currency rate changes. |
|
3 |
Net of reinsurance |
|
4 |
Refer to previously defined adjusted net investment income. |
FORWARD-LOOKING INFORMATION
The Private Securities Litigation Reform Act of 1995 provides a "safe harbor" to encourage companies to provide prospective information, so long as those informational statements are identified as forward-looking and are accompanied by meaningful cautionary statements identifying important factors that could cause actual results to differ materially from those included in the forward-looking statements. Aflac Incorporated (the Parent Company) and its subsidiaries (collectively with the Parent Company, the Company) desire to take advantage of these provisions. This document contains cautionary statements identifying important factors that could cause actual results to differ materially from those projected herein, and in any other statements made by Company officials in communications with the financial community and contained in documents filed with the Securities and Exchange Commission (SEC). Forward-looking statements are not based on historical information and relate to future operations, strategies, financial results or other developments. Furthermore, forward-looking information is subject to numerous assumptions, risks and uncertainties. In particular, statements containing words such as "expect," "anticipate," "believe," "goal," "objective," "may," "should," "estimate," "intends," "projects," "will," "assumes," "potential," "target," "outlook" or similar words as well as specific projections of future results, generally qualify as forward-looking. The Company undertakes no obligation to update such forward-looking statements.
The Company cautions readers that the following factors, in addition to other factors mentioned from time to time, could cause actual results to differ materially from those contemplated by the forward-looking statements:
Analyst and investor contact - David A. Young, 706.596.3264; 800.235.2667 or [email protected]
Media contact - Ines Gutzmer, 762.207.7601 or [email protected]
SOURCE Aflac Incorporated
| 1 hour | |
| 1 hour | |
| 2 hours | |
| 3 hours | |
| 3 hours | |
| Nov-03 | |
| Nov-02 | |
| Nov-02 | |
| Oct-30 | |
| Oct-30 | |
| Oct-30 | |
| Oct-28 | |
| Oct-27 | |
| Oct-24 | |
| Oct-19 |
Join thousands of traders who make more informed decisions with our premium features. Real-time quotes, advanced visualizations, backtesting, and much more.
Learn more about FINVIZ*Elite